Reuters logo
BRIEF-Genetic Technologies and the University of Melbourne enter into worldwide license agreement to develop colorectal cancer risk assessment test
November 29, 2016 / 11:15 AM / in a year

BRIEF-Genetic Technologies and the University of Melbourne enter into worldwide license agreement to develop colorectal cancer risk assessment test

Nov 29 (Reuters) - Genetic Technologies Ltd

* Genetic Technologies Limited and the University of Melbourne enter into exclusive worldwide license agreement to develop colorectal cancer risk assessment test Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below